Distinct functional significance of Akt and mTOR constitutive activation in mantle cell lymphoma
- 15 May 2008
- journal article
- Published by American Society of Hematology in Blood
- Vol. 111 (10), 5142-5151
- https://doi.org/10.1182/blood-2007-07-103481
Abstract
Functional characterization of signaling pathways that critically control mantle cell lymphoma (MCL) cell growth and survival is relevant to designing new therapies for this lymphoma. We herein demonstrate that the constitutive activation of Akt correlates with the expression of the phosphorylated, inactive form of PTEN. Phosphatidyl-inositol-3 kinase (PI3-K)/Akt or mammalian target of rapamycin (mTOR) inhibition decreased the growth of both primary MCL cultures and established cell lines and antagonizes the growth-promoting activity of CD40 triggering and IL-4. These effects are mediated by nuclear accumulation of the p27Kip1 inhibitor induced by down-regulation of the p45Skp2 and Cks1 proteins, which target p27Kip1 for degradation. Moreover, Akt inhibition down-regulated cyclin D1 by promoting its proteasome-dependent degradation driven by GSK-3. Intriguingly, mTOR inhibition affected cyclin D1 proteolysis only in MCL cells in which GSK-3 is under the direct control of mTOR, suggesting that different MCL subsets could be differently responsive to mTOR inhibition. Finally, PI3-K/Akt inhibitors, but not rapamycin, induced variable levels of caspase-dependent apoptosis and reduced telomerase activity. These results indicate that Akt and mTOR activation have distinct functional relevance in MCL and suggest that targeting Akt may result in more effective therapeutic effects compared with mTOR inhibition.This publication has 48 references indexed in Scilit:
- Activation of Mammalian Target of Rapamycin Signaling Promotes Cell Cycle Progression and Protects Cells from Apoptosis in Mantle Cell LymphomaThe American Journal of Pathology, 2006
- Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphomaBlood, 2006
- Rapamycin inhibits hTERT telomerase mRNA expression, independent of cell cycle arrestGynecologic Oncology, 2006
- Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesisNature Reviews Cancer, 2006
- Perturbations of the AKT signaling pathway in human cancerOncogene, 2005
- Role of Glycogen Synthase Kinase 3β in Rapamycin-Mediated Cell Cycle Regulation and ChemosensitivityCancer Research, 2005
- Constitutive activation of phosphatidyl-inositide 3 kinase contributes to the survival of Hodgkin's lymphoma cells through a mechanism involving Akt kinase and mTORThe Journal of Pathology, 2005
- Induction of hTERT expression and phosphorylation by estrogen via Akt cascade in human ovarian cancer cell linesOncogene, 2004
- Phosphorylation of the PTEN Tail Acts as an Inhibitory Switch by Preventing Its Recruitment into a Protein ComplexOnline Journal of Public Health Informatics, 2001
- Human Immunodeficiency Virus Type 1 Modulates Telomerase Activity in Peripheral Blood LymphocytesThe Journal of Infectious Diseases, 2001